Science Explorer Back to mapMap
Discussion
Company · Tokyo · Japan

Taisho Pharmaceutical (Japan)

In research, Taisho Pharmaceutical (Japan) stands highest in Chemistry (#2,403 of 2,902 worldwide), Neuroscience (#1,868 of 2,157 worldwide) and Biochemistry, Genetics and Molecular Biology (#5,222 of 5,801 worldwide), over all time.

World rank, all time
#32,755
of 34,923
Rank in Japan
#1,623
of 1,923
Research works
1.1k
▼ 30% vs 2018-21
Citations
27k
24.9 per fractional work
Top-10% rate
12.9%
all institutions 10.0%
vs its own fields
0.73×
1.00× is exactly expected
Open access
41%
world 40%
International
6%
world 18%

What is Taisho Pharmaceutical (Japan) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
ChemistryField #2,403 of 2,902 8.0%131
NeuroscienceField #1,868 of 2,157 5.2%130
Biochemistry, Genetics and Molecular BiologyField #5,222 of 5,801 5.4%286
Life SciencesDomain #9,949 of 11,023 5.5%517
Molecular BiologySubfield #3,451 of 3,729 4.7%186
MedicineField #13,822 of 14,558 7.4%331
Health SciencesDomain #15,987 of 16,688 7.1%353
Physical SciencesDomain #17,314 of 17,446 7.0%188

Each strip is that field's whole ranked pool, with the notch where Taisho Pharmaceutical (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Taisho Pharmaceutical (Japan) work in?

In 2022-now, 58% of research at Taisho Pharmaceutical (Japan) is in Health Sciences, 33% in Life Sciences. Its largest fields are Medicine (57%), Biochemistry, Genetics and Molecular Biology (21%), Neuroscience (5%). It does 2.1× the world's share of Health Sciences.

Health Sciences: 25 fractional works · 57.5% of its workMedicine: 25 fractional works · 56.9% of its workOncology: 3 fractional works · 6.6% of its workRheumatology: 3 fractional works · 5.9% of its workOrthopedics and Sports Medicine: 2 fractional works · 5.0% of its workPathology and Forensic Medicine: 2 fractional works · 4.7% of its workRehabilitation: 2 fractional works · 4.5% of its workPharmacology: 2 fractional works · 3.4% of its workPhysiology: 1 fractional works · 3.2% of its workEpidemiology: 1 fractional works · 2.6% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 2.4% of its workHematology: 1 fractional works · 2.4% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.4% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.0% of its workNephrology: 1 fractional works · 1.7% of its workDermatology: 1 fractional works · 1.6% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.5% of its workInfectious Diseases: 1 fractional works · 1.5% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.9% of its workGenetics: 0 fractional works · 0.9% of its workImmunology and Allergy: 0 fractional works · 0.8% of its workUrology: 0 fractional works · 0.8% of its workGastroenterology: 0 fractional works · 0.6% of its workSurgery: 0 fractional works · 0.6% of its workComplementary and alternative medicine: 0 fractional works · 0.4% of its workNursing: 0 fractional works · 0.5% of its workNutrition and Dietetics: 0 fractional works · 0.5% of its workHealth Professions: 0 fractional works · 0.2% of its workLife Sciences: 14 fractional works · 32.5% of its workBiochemistry, Genetics and Molecular Biology: 9 fractional works · 20.6% of its workMolecular Biology: 3 fractional works · 6.6% of its workCell Biology: 2 fractional works · 4.8% of its workCancer Research: 2 fractional works · 4.4% of its workBiochemistry: 1 fractional works · 1.9% of its workMolecular Medicine: 1 fractional works · 1.5% of its workClinical Biochemistry: 0 fractional works · 0.8% of its workBiotechnology: 0 fractional works · 0.4% of its workEndocrinology: 0 fractional works · 0.2% of its workNeuroscience: 2 fractional works · 5.0% of its workCognitive Neuroscience: 1 fractional works · 1.7% of its workBiological Psychiatry: 0 fractional works · 1.1% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.0% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.8% of its workDevelopmental Neuroscience: 0 fractional works · 0.4% of its workImmunology and Microbiology: 2 fractional works · 3.8% of its workImmunology: 2 fractional works · 3.8% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 2.4% of its workPharmacology: 1 fractional works · 1.5% of its workPharmaceutical Science: 0 fractional works · 0.8% of its workAgricultural and Biological Sciences: 0 fractional works · 0.8% of its workFood Science: 0 fractional works · 0.4% of its workPlant Science: 0 fractional works · 0.4% of its workPhysical Sciences: 3 fractional works · 6.4% of its workChemistry: 1 fractional works · 2.7% of its workOrganic Chemistry: 1 fractional works · 1.5% of its workSpectroscopy: 0 fractional works · 0.9% of its workAnalytical Chemistry: 0 fractional works · 0.3% of its workEngineering: 1 fractional works · 2.0% of its workCivil and Structural Engineering: 0 fractional works · 1.1% of its workSafety, Risk, Reliability and Quality: 0 fractional works · 0.4% of its workElectrical and Electronic Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEnvironmental Science: 0 fractional works · 1.1% of its workEnvironmental Engineering: 0 fractional works · 0.4% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.4% of its workManagement, Monitoring, Policy and Law: 0 fractional works · 0.4% of its workMaterials Science: 0 fractional works · 0.3% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workMathematics: 0 fractional works · 0.3% of its workModeling and Simulation: 0 fractional works · 0.3% of its workSocial Sciences: 2 fractional works · 3.5% of its workPsychology: 2 fractional works · 3.5% of its workExperimental and Cognitive Psychology: 1 fractional works · 3.1% of its workSocial Psychology: 0 fractional works · 0.4% of its workALL ITS WORKTaishoPharmaceutical…44fractional works, 2022-now
Life Sciences33%Physical Sciences6%Health Sciences58%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Medicine2556.9%
    2. Nursing00.5%
    3. Health Professions00.2%
    1. Biochemistry, Genetics and Molecular Biology920.6%
    2. Neuroscience25.0%
    3. Immunology and Microbiology23.8%
    4. Pharmacology, Toxicology and Pharmaceutics12.4%
    5. Agricultural and Biological Sciences00.8%
    1. Chemistry12.7%
    2. Engineering12.0%
    3. Environmental Science01.1%
    4. Materials Science00.3%
    5. Mathematics00.3%
    1. Psychology23.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.16× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.86× its world share, 9 worksBiochemistry, Geneti…Immunology and Microbiology: 3.79× its world share, 2 worksImmunology and Micro…Neuroscience: 3.08× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 6.67× its world share, 1 worksPharmacology, Toxico…Chemistry: 1.74× its world share, 1 worksChemistryEngineering: 0.13× its world share, 1 worksEngineeringEnvironmental Science: 0.23× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.08× its world share, 0 worksMaterials ScienceMathematics: 0.22× its world share, 0 worksMathematicsHealth Professions: 0.07× its world share, 0 worksHealth ProfessionsMedicine: 2.96× its world share, 25 worksMedicineNursing: 1.04× its world share, 0 worksNursingPsychology: 1.16× its world share, 2 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.7×. Every wedge is a field page.

All 14 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics6.67×1 works
  2. Biochemistry, Genetics and Molecular Biology3.86×9 works
  3. Immunology and Microbiology3.79×2 works
  4. Neuroscience3.08×2 works
  5. Medicine2.96×25 works
  6. Chemistry1.74×1 works
  7. Psychology1.16×2 works
  8. Nursing1.04×0 works
  9. Environmental Science0.23×0 works
  10. Mathematics0.22×0 works
  11. Agricultural and Biological Sciences0.16×0 works
  12. Engineering0.13×1 works
  13. Materials Science0.08×0 works
  14. Health Professions0.07×0 works

Who are the top researchers at Taisho Pharmaceutical (Japan)?

Ranked on the quality score, Kenichi Fukumoto, Mari Aoki and Yukihiro Chino lead among researchers whose main affiliation is Taisho Pharmaceutical (Japan).

  1. 1 Kenichi Fukumoto Japan · #840,689 worldwide 1.5k citations · 26 works
  2. 2 Mari Aoki Japan · #1,664,620 worldwide 1.9k citations · 81 works
  3. 3 Yukihiro Chino Japan · #3,709,295 worldwide 917 citations · 24 works
  4. 4 Michihiko Iijima Japan · #3,758,691 worldwide 2.4k citations · 33 works
  5. 5 Mitsuo Murata Japan · #3,816,183 worldwide 2k citations · 45 works
  6. 6 Takemasa Kojima Japan · #3,822,501 worldwide 806 citations · 21 works
  7. 7 Masaharu Tamai Japan · #3,926,835 worldwide 1.2k citations · 21 works
  8. 8 Noriyuki Miyata Japan · #3,938,838 worldwide 3.2k citations · 73 works
  9. 9 Yuji Takaoka Japan · #3,973,130 worldwide 1.2k citations · 38 works
  10. 10 Kazunori Hanada Japan · #4,209,197 worldwide 3.9k citations · 83 works
All ranked researchers at Taisho Pharmaceutical (Japan)

What are the most cited papers from Taisho Pharmaceutical (Japan)?

The most cited paper from Taisho Pharmaceutical (Japan) is "L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L" (A. John Barrett, A A Kembhavi, Molly A. Brown et al., 1982), with 1,031 citations. Next come "Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor" (868) and "NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro" (833).

Most cited papers
#PaperReleasedCitations
1 L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L A. John Barrett, A A Kembhavi, Molly A. Brown et al. · Biochemical Journal Open access 1982 1,031
2 Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor Toshihiro Ichiki, Patricia Ann Labosky, Chiyo Shiota et al. · Nature Oct 1995 868
3 NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro Nobuko Futaki, Satoru Takahashi, Motofumi Yokoyama et al. · Prostaglandins 1994 833
4 α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy Koichi Wakabayashi, Makoto Yoshimoto, Shoji Tsuji et al. · Neuroscience Letters Jun 1998 659
5 The gamete fusion process is defective in eggs of Cd9-deficient mice Keisuke Kaji, Shoji Oda, Tomohide Shikano et al. · Nature Genetics Mar 2000 497
All 60 most cited papers, with filters and sorting

Which keywords describe research at Taisho Pharmaceutical (Japan)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Inflammation, Angiogenesis, Metabolism, Autoantibodies, Cancer Therapy, Resistance Training, Cell Signaling and Reactive Oxygen Species.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation6▲ 6.6×20 topics
  2. Angiogenesis4▲ 28×5 topics
  3. Metabolism3▲ 14×8 topics
  4. Autoantibodies3▲ 29×3 topics
  5. Cancer Therapy3▲ 11×6 topics
  6. Epidemiology3▲ 1.57×11 topics
  7. Cell Signaling2▲ 35×4 topics
  8. Resistance Training2▲ 60×2 topics
  9. Reactive Oxygen Species2▲ 12×3 topics
  10. Cancer Progression2▲ 26×2 topics
  11. Tumor Microenvironment2▲ 10×3 topics
  12. Immune Function2▲ 56×2 topics
  13. Cytokines2▲ 14×4 topics
  14. Exercise-Induced Oxidative Stress2▲ 137×1 topic
  15. Fibrosis2▲ 21×3 topics
  16. Muscle-Derived Interleukin-62▲ 137×1 topic
  17. Oxidative Stress2▲ 2.5×8 topics
  18. Extracellular Matrix2▲ 22×2 topics
  19. Matrix Metalloproteinases2▲ 28×3 topics
  20. Toll-like Receptors2▲ 35×3 topics
  21. Metabolic Syndrome2▲ 4.6×5 topics
  22. Cytochrome P4502▲ 105×2 topics
  23. Extracellular Matrix Remodeling2▲ 223×1 topic
  24. Fibroblast Activation Protein2▲ 81×1 topic
  25. Immunosuppression2▲ 38×1 topic
  26. Performance Analysis2▲ 17×1 topic
  27. Synaptic Plasticity2▲ 16×3 topics
  28. Tissue Inhibitors of Metalloproteinases2▲ 223×1 topic
  29. Training Load2▲ 53×1 topic
  30. Circadian Rhythms1▲ 28×2 topics
  31. Hypertension1▲ 11×3 topics
  32. Pulmonary Involvement1▲ 73×1 topic
  33. Systemic Sclerosis1▲ 73×1 topic
  34. Transcriptional Regulation1▲ 17×3 topics
  35. Cardiovascular Function1▲ 68×2 topics
  36. Exercise1▲ 21×2 topics
  37. Rheumatoid Arthritis1▲ 26×2 topics
  38. Monoclonal Antibodies1▲ 26×2 topics
  39. Nutrition1▲ 5.3×2 topics
  40. Therapeutic Targets1▲ 15×3 topics

Which research topics does Taisho Pharmaceutical (Japan) publish most on?

By volume in 2022-now: Exercise and Physiological Responses, Sports Performance and Training, Peptidase Inhibition and Analysis and Protease and Inhibitor Mechanisms.

  1. 1 Exercise and Physiological Responses Rehabilitation 2 works
  2. 2 Sports Performance and Training Orthopedics and Sports Medicine 2 works
  3. 3 Peptidase Inhibition and Analysis Oncology 2 works
  4. 4 Protease and Inhibitor Mechanisms Cancer Research 2 works
  5. 5 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 1 works
  6. 6 Systemic Lupus Erythematosus Research Rheumatology 1 works
  7. 7 Muscle metabolism and nutrition Cell Biology 1 works
  8. 8 Rheumatoid Arthritis Research and Therapies Rheumatology 1 works
  9. 9 Eicosanoids and Hypertension Pharmacology Biochemistry 1 works
  10. 10 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.0%not open59.0%

World: 40% of research is openly available.

with international co-authors5.9%domestic only94.1%

World: 18% is written across borders.

How has Taisho Pharmaceutical (Japan)'s research output changed?

Output in 2022-2025 was 30% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Taisho Pharmaceutical (Japan) as a percentage of every work published that year, 0.00014% in 2024.

still counting0.0020%0.0040%0.0060%Taisho Pharmaceutical (Japan)0.000068% in 202519801990200020102020

Fractional works of Taisho Pharmaceutical (Japan) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

5%10%15%all institutions10.0% in 2009Taisho Pharmaceutical (Japan)2.1% in 20092000

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 14.7% in 1997.

Share Taisho Pharmaceutical (Japan)'s ranking

Taisho Pharmaceutical (Japan) on Science Explorer

A card with Taisho Pharmaceutical (Japan)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Taisho Pharmaceutical (Japan). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.